Our findings suggest that IRF8 expression levels are upregulated in both human and murine AAA samples, potentially accelerating aneurysm development by promoting the differentiation of cDC1s and the activation of CD8+ T cells. The gene discussed is CD8A; the disease is triple-A syndrome.